Q/C Technologies, Inc. Other Current Liabilities
Q/C Technologies, Inc. (QCLS) had Other Current Liabilities of $29.98 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Other Liabilities, Current $29.98K.
- 2026-03-31: Other Liabilities, Current $29.98K.
- 2025-12-31: Other Liabilities, Current $29.98K.
- 2025-09-30: Other Liabilities, Current $29.98K.
| Period end | Other Liabilities, Current |
|---|---|
| 2026-06-30 | $29.98K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $29.98K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $29.98K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $29.98K 10-Q · filed 2025-11-19 |
| 2024-12-31 | $29.98K 10-K · filed 2026-04-15 |
| 2023-03-31 | $29.98K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $29.98K 10-Q · filed 2023-05-15 |
| 2014-09-30 | $414.33K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $348.14K 10-Q · filed 2014-08-12 |
| 2014-03-31 | $461.78K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $377.26K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |